ArtiQ, an innovative spin-off startup of KU Leuven (Belgium) which helps doctors diagnose, treat and monitor respiratory problems has announced that it has successfully concluded its seed financing round, raising € 1 million. KU Leuven is Europe’s one of the most innovative universities. Located in Belgium, it is dedicated to research, education, and service to society.
The financing will be used to launch ArtiQ|PFT, a decision support tool that offers pulmonologists a fast, reliable and standardised evaluation of a patient’s lung function. The investors are KBC Focus Fund, the KU Leuven Gemma Frisius Fund, University Hospitals Leuven and private investor Bart Swaelens. ArtiQ is part of the accelerator Start it @KBC that supports innovative and scalable entrepreneurship.